Optimal Patient Population in the JAVELIN Bladder 100-trial
In this MEDtalk, Jeanny B. Aragon-Ching, Associate Professor at the University of Virginia, gives a short overview of the effect on several subgroups of patients in the JAVALIN Blader 100 trial.
